| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $423.5M | +2.0% | +15.9% |
| Cost of Revenue | $102.0M | +5.5% | +9.5% |
| Gross Profit | $321.5M | +0.9% | +18.1% |
| R&D Expense | $108.2M | -0.9% | +22.7% |
| SG&A Expense | $48.0M | +7.0% | +8.8% |
| Operating Income | -$8.2M | +12.8% | -86.1% |
| Interest Expense | $6.3M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $800.6M | +20.9% | +21.6% |
| Short-term Investments | $595.5M | -28.4% | — |
| Accounts Receivable | $260.9M | +17.6% | +1.9% |
| Current Assets | $1.83B | -2.8% | +15.8% |
| Total Assets | $2.48B | -1.9% | +11.0% |
| Current Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $131.4M | +25.4% | — |
| Capital Expenditures | $1.3M | +92.2% | — |
| Investing Cash Flow | $38.4M | +122.5% | — |
| Financing Cash Flow | -$96.7M | — | — |
| Free Cash Flow | $130.2M | +25.0% | — |
| -0.9% |
| -2.6% |
| Pre-tax Income | $1.3M | — | +173.4% |
| Income Tax | $52.6M | +113.8% | +122.2% |
| Net Income | -$51.3M | -108.4% | -101.5% |
| EPS (Basic) | -$0.48 | -108.7% | -92.0% |
| EPS (Diluted) | -$0.48 | -108.7% | -92.0% |
| $927.0M |
| +2.9% |
| +17.2% |
| Long-term Debt | $570.3M | +0.1% | +0.2% |
| Total Liabilities | $1.59B | +2.1% | +11.7% |
| Stockholders' Equity | $891.1M | -8.3% | +9.8% |